Skip to content

EV / EBITDA at other companies

Danaher logo
DanaherDHR
20.5×-2.1×
Medtronic logo
MedtronicMDT
13.9×-1.5×
Stryker logo
StrykerSYK
22.1×-11.8×
Boston Scientific logo
Boston ScientificBSX
28.3×-8.5×
Agilent Technologies logo
Agilent TechnologiesA
18.8×-0.5×
Cardinal Health logo
Cardinal HealthCAH
16.9×+4.4×

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$27.82B-12.0%
P/E14.6×+0.1×
P/S1.3×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Calculated from GE HealthCare Technologies’s reported figures.

Based on the most recent quarter.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's EV / EBITDA?
GE HealthCare Technologies (GEHC) reported EV / EBITDA of 13.3× in Q1 2026.
How has GE HealthCare Technologies's EV / EBITDA changed year-over-year?
GE HealthCare Technologies's EV / EBITDA decreased by 5.5% year-over-year, from 14× to 13.3×.
What is the long-term trend for GE HealthCare Technologies's EV / EBITDA?
Over 2 years (2023 to 2025), GE HealthCare Technologies's EV / EBITDA has grown at a -2.6% compound annual growth rate (CAGR), from 58.1× to 55.1×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.